Related Articles
PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells
Plasminogen activator inhibitor-1 in kidney pathology (Review)
Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure
Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice
Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report